These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37191946)

  • 21. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
    Chen Y; Dyakin VV; Branch CA; Ardekani B; Yang D; Guilfoyle DN; Peterson J; Peterhoff C; Ginsberg SD; Cataldo AM; Nixon RA
    Neurobiol Aging; 2009 Sep; 30(9):1453-65. PubMed ID: 18180075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease.
    Alldred MJ; Lee SH; Stutzmann GE; Ginsberg SD
    Front Aging Neurosci; 2021; 13():707950. PubMed ID: 34489678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.
    Yan J; Ginsberg SD; Powers B; Alldred MJ; Saltzman A; Strupp BJ; Caudill MA
    FASEB J; 2014 Oct; 28(10):4312-23. PubMed ID: 24963152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.
    Martinez JL; Zammit MD; West NR; Christian BT; Bhattacharyya A
    Front Aging Neurosci; 2021; 13():703876. PubMed ID: 34322015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
    Liu W; Li J; Yang M; Ke X; Dai Y; Lin H; Wang S; Chen L; Tao J
    Alzheimers Res Ther; 2022 Apr; 14(1):53. PubMed ID: 35418161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.
    Jiang Y; Rigoglioso A; Peterhoff CM; Pawlik M; Sato Y; Bleiwas C; Stavrides P; Smiley JF; Ginsberg SD; Mathews PM; Levy E; Nixon RA
    Neurobiol Aging; 2016 Mar; 39():90-8. PubMed ID: 26923405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
    Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS
    Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
    Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis.
    Orciani C; Hall H; Pentz R; Foret MK; Do Carmo S; Cuello AC
    J Neurochem; 2022 Oct; 163(2):149-167. PubMed ID: 35921478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different cholinergic cell groups in the basal forebrain regulate social interaction and social recognition memory.
    Okada K; Nishizawa K; Kobayashi T; Sakata S; Hashimoto K; Kobayashi K
    Sci Rep; 2021 Jun; 11(1):13589. PubMed ID: 34193944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
    Hunter CL; Bachman D; Granholm AC
    Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.
    Ahmadian SS; Rezvanian A; Peterson M; Weintraub S; Bigio EH; Mesulam MM; Geula C
    Neurobiol Aging; 2015 Dec; 36(12):3163-3170. PubMed ID: 26417681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model.
    Kerbler GM; Hamlin AS; Pannek K; Kurniawan ND; Keller MD; Rose SE; Coulson EJ
    Neuroimage; 2013 Feb; 66():133-41. PubMed ID: 23128077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal and brain region-specific elevations of soluble Amyloid-β
    Tallino S; Winslow W; Bartholomew SK; Velazquez R
    Aging Cell; 2022 Apr; 21(4):e13590. PubMed ID: 35290711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
    Lockrow J; Prakasam A; Huang P; Bimonte-Nelson H; Sambamurti K; Granholm AC
    Exp Neurol; 2009 Apr; 216(2):278-89. PubMed ID: 19135442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology.
    Mesulam MM; Lalehzari N; Rahmani F; Ohm D; Shahidehpour R; Kim G; Gefen T; Weintraub S; Bigio E; Geula C
    Neurology; 2019 Apr; 92(14):e1580-e1588. PubMed ID: 30842294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
    Alldred MJ; Pidikiti H; Ibrahim KW; Lee SH; Heguy A; Hoffman GE; Mufson EJ; Stutzmann GE; Ginsberg SD
    J Alzheimers Dis; 2024 Jul; ():. PubMed ID: 39031371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.